NSCLC (Non-small Cell Lung Cancer) Clinical Trials in Rochester, Minnesota

3 studies are recruiting for nsclc (non-small cell lung cancer) in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Pan-tumor MRD Study

    The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, f…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    47 in total
    Run by
    Paradigm Health

    See if you can join NCT06605404 on ClinicalTrials.gov

  2. A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

    This is a multi-center, first-in-human, open label, dose escalation (Part A) and expansion (Part B) Phase 1 study in subjects with advanced solid tumors and in subjects with solid tumors with selected genetic alterations that are either direct (YES1 amplification) or dependent (Hippo Pathway altera…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Mayo Clinic Rochester, Rochester, Minnesota
    Locations
    15 in total
    Run by
    Nuvectis Pharma, Inc.

    See if you can join NCT05873686 on ClinicalTrials.gov

  3. A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

    The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), triple-negative breast cancer (TNBC), renal cell carcinoma…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    10 in total
    Run by
    A2 Biotherapeutics Inc.

    See if you can join NCT06682793 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.